TECH
Price
$48.70
Change
+$0.39 (+0.81%)
Updated
Jun 6, 04:59 PM (EDT)
Capitalization
7.57B
67 days until earnings call
VCEL
Price
$43.21
Change
-$0.19 (-0.44%)
Updated
Jun 6, 04:44 PM (EDT)
Capitalization
2.19B
54 days until earnings call
Interact to see
Advertisement

TECH vs VCEL

Header iconTECH vs VCEL Comparison
Open Charts TECH vs VCELBanner chart's image
Bio-Techne
Price$48.70
Change+$0.39 (+0.81%)
Volume$21.14K
Capitalization7.57B
Vericel
Price$43.21
Change-$0.19 (-0.44%)
Volume$200
Capitalization2.19B
TECH vs VCEL Comparison Chart
Loading...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TECH vs. VCEL commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TECH is a Buy and VCEL is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (TECH: $48.28 vs. VCEL: $43.41)
Brand notoriety: TECH and VCEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TECH: 90% vs. VCEL: 74%
Market capitalization -- TECH: $7.57B vs. VCEL: $2.19B
TECH [@Biotechnology] is valued at $7.57B. VCEL’s [@Biotechnology] market capitalization is $2.19B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TECH’s FA Score shows that 1 FA rating(s) are green whileVCEL’s FA Score has 0 green FA rating(s).

  • TECH’s FA Score: 1 green, 4 red.
  • VCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, TECH is a better buy in the long-term than VCEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TECH’s TA Score shows that 4 TA indicator(s) are bullish while VCEL’s TA Score has 6 bullish TA indicator(s).

  • TECH’s TA Score: 4 bullish, 3 bearish.
  • VCEL’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, VCEL is a better buy in the short-term than TECH.

Price Growth

TECH (@Biotechnology) experienced а -0.10% price change this week, while VCEL (@Biotechnology) price change was +4.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.92%. For the same industry, the average monthly price growth was +17.56%, and the average quarterly price growth was +3.51%.

Reported Earning Dates

TECH is expected to report earnings on Aug 12, 2025.

VCEL is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+11.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECH($7.57B) has a higher market cap than VCEL($2.19B). VCEL has higher P/E ratio than TECH: VCEL (868.20) vs TECH (58.17). VCEL YTD gains are higher at: -20.943 vs. TECH (-32.783). TECH has higher annual earnings (EBITDA): 283M vs. VCEL (10.6M). VCEL has less debt than TECH: VCEL (99M) vs TECH (395M). TECH has higher revenues than VCEL: TECH (1.21B) vs VCEL (239M).
TECHVCELTECH / VCEL
Capitalization7.57B2.19B346%
EBITDA283M10.6M2,670%
Gain YTD-32.783-20.943157%
P/E Ratio58.17868.207%
Revenue1.21B239M506%
Total CashN/A113M-
Total Debt395M99M399%
FUNDAMENTALS RATINGS
TECH vs VCEL: Fundamental Ratings
TECH
VCEL
OUTLOOK RATING
1..100
258
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
97
Overvalued
PROFIT vs RISK RATING
1..100
10058
SMR RATING
1..100
8088
PRICE GROWTH RATING
1..100
6460
P/E GROWTH RATING
1..100
62100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (3) in the Biotechnology industry is significantly better than the same rating for VCEL (97) in the Medical Specialties industry. This means that TECH’s stock grew significantly faster than VCEL’s over the last 12 months.

VCEL's Profit vs Risk Rating (58) in the Medical Specialties industry is somewhat better than the same rating for TECH (100) in the Biotechnology industry. This means that VCEL’s stock grew somewhat faster than TECH’s over the last 12 months.

TECH's SMR Rating (80) in the Biotechnology industry is in the same range as VCEL (88) in the Medical Specialties industry. This means that TECH’s stock grew similarly to VCEL’s over the last 12 months.

VCEL's Price Growth Rating (60) in the Medical Specialties industry is in the same range as TECH (64) in the Biotechnology industry. This means that VCEL’s stock grew similarly to TECH’s over the last 12 months.

TECH's P/E Growth Rating (62) in the Biotechnology industry is somewhat better than the same rating for VCEL (100) in the Medical Specialties industry. This means that TECH’s stock grew somewhat faster than VCEL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TECHVCEL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 24 days ago
72%
Bearish Trend 5 days ago
72%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MCHI54.990.20
+0.37%
iShares MSCI China ETF
SCHQ31.25-0.02
-0.06%
Schwab Long-Term US Treasury ETF
IWML17.38-0.05
-0.27%
ETRACS 2x Leveraged US Size Fctr TR ETN
DSEP41.22-0.13
-0.32%
FT Vest US Equity Dp Bffr ETF Sep
STNC30.24-0.20
-0.66%
Hennessy Sustainable ETF

VCEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCEL has been loosely correlated with VCYT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VCEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCEL
1D Price
Change %
VCEL100%
+0.56%
VCYT - VCEL
52%
Loosely correlated
-1.17%
BEAM - VCEL
44%
Loosely correlated
-0.87%
MNMD - VCEL
44%
Loosely correlated
+0.52%
TECH - VCEL
41%
Loosely correlated
-3.15%
CRBU - VCEL
40%
Loosely correlated
-3.54%
More